Metropolis Healthcare Limited operates a chain of diagnostic centers and hospital laboratories in India, the United Arab Emirates, Sri Lanka, South Africa, Kenya, Mauritius, and Ghana.

The company is planning to add 800 collection centres and around 10 laboratories by the end of next fiscal, said Ameera Shah, Metropolis Healthcare Promoter and Managing Director.

The company currently has 150 labs with 1,800 collection centres and processes over 4,500 varieties of tests.

As part of the company's growth strategy, it would expand its geographical presence in North and Eastern parts of the country while growing depth in South and West, she added.

During the last year, the company has set up labs in Ludhiana, Khanna, Ghaziabad, Dhanbad. We have also added labs in Kolkata, Patna and Delhi, she added.

About the southern and western regions of the country, Shah said: "We are very clear leaders in West and South. Here we have to build much more depth. We are going deeper and nearer to the patients."

"In Africa we will keep growing, we are looking to enter one or more countries there." Shah said on expansion of company.

The interest is now on building dominance and market leadership in the places that the company is present, she added.

Shah said: "Expansion will be done through internal accruals. We are also planning to invest around Rs 60 crore over the next two to three years in technology."

The company had entered a public-private partnership three months ago with National Aids Control Organisation (NACO) for a three-year project to organise collection of blood and testing for HIV at 560 locations across India.

Metropolis Healthcare conducts more than 30 million tests a year catering to over 20,000 laboratories, hospitals, nursing homes and 2 lakh consultants.

It offers comprehensive testing in the areas of genetics biochemistry, molecular oncology, anatomic pathology, microbiology, haematology, immunochemistry, among others.